Posted by Hugo Ottolenghi
May 26th, 2010
Nearly all of the herbal dietary supplements tested in a Congressional investigation contained trace amounts of lead and other contaminants, and some supplement sellers made illegal claims that their products can cure cancer and other diseases, investigators found. So begins an article in the New York Times on a Government Accounting Office report released May [...]
Posted by Hugo Ottolenghi
January 18th, 2010
GUEST POST BY DAVID MARK The Washington Post recently published an article asserting that vitamin D is shaping up to be the nutrient of the year, if not the decade. The article started factually strong but weakened at the end when it made specific recommendations. The Post references an article in Consumer Reports titled “Most [...]
Posted by Hugo Ottolenghi
December 13th, 2009
The first paragraph in the New York Times story said it all: “The Drug Enforcement Administration has classified as controlled substances three steroids that are marketed as dietary supplements, but an antidoping official warned that new steroids have taken their place on the shelves of nutrition stores.” The DEA’s actions are the equivalent of the [...]
Posted by Hugo Ottolenghi
November 28th, 2009
David Frum could have lowered his rhetorical blood pressure in his CNN.com guest commentary on the evils of dietary supplement marketing by reading the FTC regulations that go into effect on Tuesday. His column then would have begun: The party is over Dec. 1.
Posted by Hugo Ottolenghi
November 22nd, 2009
News reports bring into question the efficacy and safety of some vitamins. However, there is an even greater threat from a product with no proven side effects and a very low price.
Posted by Hugo Ottolenghi
November 16th, 2009
Two days of hearings before the FDA about search-based advertising for drugs produced one possible solution: fixed warnings for products. Google has proposed that its AdWords could include a hyperlinked line that warns consumers about the potential dangers of a drug.